Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888274 · ClinicalTrials.gov registry record · NA
ClearUP Longitudinal Pilot Study
A NA study of Congestion and Sinus Pain, sponsored by Tivic Health Systems.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03888274: Completed NA study of Congestion and Sinus Pain, sponsored by Tivic Health Systems.
NCT03888274 is a NA study of Congestion and Sinus Pain that has completed, run by Tivic Health Systems. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03888274, a NA study of Congestion and Sinus Pain, has completed, sponsored by Tivic Health Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.
Primary Outcome
Change in Numeric Rating Scale for Pain from Baseline to Four Weeks. Scale range 0, no pain, to 10 severe pain.
Conditions Studied
Interventions
- DEVICE ClearUP Sinus Pain Relief
Study Locations (1)
California
- Allergy and Asthma Associates of Santa Clara Valley Research Center - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
What the finished NCT03888274 record still lists
NCT03888274 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Congestion appearing as the primary indexed condition, and to 1 intervention - of which ClearUP Sinus Pain Relief is the first listed.
NCT03888274 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03888274 about?
NCT03888274 is a clinical study titled "ClearUP Longitudinal Pilot Study". Single arm, open label pilot study assessing the longitudinal home use of ClearUp Sinus Pain Relief for four weeks.
What is the current status of trial NCT03888274?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-11-29. Estimated completion is 2019-03-01.
What conditions does trial NCT03888274 study?
This clinical trial studies the following conditions: Congestion, Sinus Pain.
What interventions are being tested in trial NCT03888274?
The interventions under investigation include: ClearUP Sinus Pain Relief (DEVICE).
Who is sponsoring clinical trial NCT03888274?
This trial is sponsored by Tivic Health Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03888274 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03888274's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI